What smart money is saying about Kymera Therapeutics
KYMR
No fund has written a full thesis on Kymera Therapeutics in our archive, but 1 fund letter reports a position in it, most recently ClearBridge Investments SMID Cap Growth Strategy in June 2026.
Get an email when a fund buys, sells or pitches it
1
Reported positions
1
Bought
0
Sold
1
Letter
Position history
Every position in Kymera Therapeutics on record in the archive was reported in Q2 2026, across 1 fund letter, with 1 buy (opened or added).
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 1 | 0 | 0 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 1 position · 1 move
- New positionClearBridge Investments SMID Cap Growth StrategyJune 2026
“In addition to the transactions mentioned above, we initiated positions in Arxis, Sterling Infrastructure, and Woodward in the industrials sector, SiTime, Cipher Digital, D-Wave Quantum and DigitalOcean in the IT sector, Liftoff Mobile in the communication services sector and Axsome Therapeutics, Vaxcyte and Kymera Therapeutics in the health care sector.”
Kymera Therapeutics
Read the letters behind these Kymera Therapeutics positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves, and to Warren AI, which reads all of them for you.
View plans→Share this ledger